Cargando…

Ribonuclease 4 is associated with aggressiveness and progression of prostate cancer

Prostate specific antigen screening has resulted in a decrease in prostate cancer-related deaths. However, it also has led to over-treatment affecting the quality of life of many patients. New biomarkers are needed to distinguish prostate cancer from benign prostate hyperplasia (BPH) and to predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanli, Nil, Sheng, Jinghao, Li, Shuping, Xu, Zhengping, Hu, Guo-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233706/
https://www.ncbi.nlm.nih.gov/pubmed/35752711
http://dx.doi.org/10.1038/s42003-022-03597-1